View of Prevalence, clinical profile and risk factors of metabolic dysfunction–associated steatotic liver disease (MASLD) in newly diagnosed type 2 diabetes mellitus

Return to Article Details Prevalence, clinical profile and risk factors of metabolic dysfunction–associated steatotic liver disease (MASLD) in newly diagnosed type 2 diabetes mellitus Download Download PDF